Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
about
A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review.Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case reportTumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.
P2860
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
@ast
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
@en
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
@nl
type
label
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
@ast
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
@en
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
@nl
prefLabel
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
@ast
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
@en
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
@nl
P2093
P2860
P356
P1476
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
@en
P2093
Christopher Zito
Harriet M Kluger
Joshua A Sznol
Laurence Albiges
Lucia B Jilaveanu
Robert L Camp
Saadia A Aziz
P2860
P2888
P356
10.1186/1475-2867-14-4
P577
2014-01-14T00:00:00Z
P5875
P6179
1002368799